about
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumorsAberrant Wnt Signaling in LeukemiaThe EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunitiesCanonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent mannerTC1(C8orf4) regulates hematopoietic stem/progenitor cells and hematopoiesisIntronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemiaDevelopmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemiaNew targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersPast visits present: TCF/LEFs partner with ATFs for β-catenin-independent activityMicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor Cells.Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.Romidepsin targets multiple survival signaling pathways in malignant T cellsDrosophila as a model for the two myeloid blood cell systems in vertebrates.Activation of wnt/β-catenin signaling blocks monocyte-macrophage differentiation through antagonizing PU.1-targeted gene transcription.The anti-apoptotic PON2 protein is Wnt/β-catenin-regulated and correlates with radiotherapy resistance in OSCC patients.E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding.Extracellular Vesicles Mediate Radiation-Induced Systemic Bystander Signals in the Bone Marrow and Spleen.Targeting the canonical Wnt/β-catenin pathway in hematological malignancies.RNA interference for multiple myeloma therapy: targeting signal transduction pathways.Ex vivo expansion of hematopoietic stem cells.Epo reprograms the epigenome of erythroid cells.WNT receptors profile expression in mature blood cells and immature leukemic cells: RYK emerges as a hallmark receptor of acute leukemia.Noncanonical Wnt5a-Ca(2+) -NFAT signaling axis in pesticide induced bone marrow aplasia mouse model: A study to explore the novel mechanism of pesticide toxicity.Wnt Signaling in Normal and Malignant Stem Cells.Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells.FAM53B truncation caused by t(10;19)(q26;q13) chromosome translocation in acute lymphoblastic leukemia.Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway.The role of Wnt signaling in hematopoietic stem cell development.GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells.Delayed Onset of Symptoms Through Feedback Interference in Chronic Cancers.Human Teratoma-Derived Hematopoiesis Is a Highly Polyclonal Process Supported by Human Umbilical Vein Endothelial Cells
P2860
Q24300043-D4E036F5-537E-4D43-93D3-3D84F8CA526BQ26738411-58AD3024-507F-4384-815D-26BB715DEA46Q27852536-33C504DF-F10E-4CBD-AE4C-3016606769F4Q28071384-E76ABE81-F277-49CC-9CD0-B85B8F99CC04Q28543151-1D2F50F9-2C10-41CD-BC93-0B99982D7DF5Q28593172-DEE6431A-A8A1-48C6-AB9B-3AC65D8D48EDQ28821250-327F88C9-21FA-4271-A7AC-E9901AB6EF4AQ33851883-D71818F1-498C-4CF0-9609-A248C17951DEQ34121336-9DEA609C-4623-438E-8D20-005C7EF5BFC1Q34706060-FAB739BB-E16D-4E3C-8A34-1BCDB66DE179Q34962032-60E98A4C-4AFF-4D93-8A22-7D1E6CFC4265Q35646359-B551D118-9D61-47C9-90B0-08833010F7B3Q35691048-88C6E1FD-5D9A-445F-BC61-35798E7B980EQ36254237-8411DDB4-FB41-4813-8ECE-FFD50BA0434CQ37235632-6FF9DA86-EC4B-42DC-99FF-494A1BB2C213Q37317796-E53F32D0-8DC0-428E-9511-7C1487875494Q37588244-E27E04F3-2859-4AA9-A4A9-5E673903F0C1Q37658959-1F6C27EB-341B-4714-8423-FD1CDBFB9AFDQ37698706-D1943BED-C2E9-4FA9-BC48-F8EC981F424AQ37721689-4573BE67-CE35-47F2-B8D2-1B461664F85AQ38383469-2AF64F14-721F-4D73-A314-7E7D8C2FF87EQ38550480-321E1AFC-DECB-4F8B-A151-5DCDE7646FD3Q38561480-0806B225-28F1-480E-9CCC-DBE1AB737C58Q38730271-BFD97712-37A6-4C56-970D-2E26C8AB1088Q38820001-E915FF2A-CED9-4219-AFB2-59E5AF8E5F11Q38940107-64328973-460B-451F-909E-68CD21F7FC8CQ39306017-83B89FCF-90CF-4B2D-BC6E-2BF7B990AB7AQ39432317-36EC0A48-1D0A-4361-BE63-642F0F2A5F36Q41909687-693DAC86-BD68-43D3-A20E-71B6E88805A4Q42290646-A2036588-4F07-43F6-9C65-4DC30ED63E22Q42517611-EE28ECF5-1AE7-4EAB-94E6-1C04283F8C49Q45971479-65B12629-B3B9-46C6-9C2E-08C16A42AF51Q54378200-EFF95BAC-2FD6-4842-B1CF-D288BCB35ADAQ55437693-8E68C18D-96EE-47A8-B621-248BFA7A9097Q57817724-717039CC-53A8-4674-8E98-7A6277FCD1EF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Wnt signaling in normal and malignant hematopoiesis.
@en
type
label
Wnt signaling in normal and malignant hematopoiesis.
@en
prefLabel
Wnt signaling in normal and malignant hematopoiesis.
@en
P2093
P2860
P1476
Wnt signaling in normal and malignant hematopoiesis.
@en
P2093
Kendra Congdon
Marcie Kritzik
William Lento
P2860
P356
10.1101/CSHPERSPECT.A008011
P577
2013-02-01T00:00:00Z